CT Pharma Research has carried out more than 200 pharmaceutical R&D projects for more than 23 customers from 2012 to 2022.

In addition to its customers, CT Pharma Research carries out R&D projects for itself, and also benefits from TÜBİTAK Teydep support in these projects. Within the scope of TÜBİTAK Teydep 1507, it has successfully completed the R&D project for the equivalent drug in tablet solid dosage form in 2015. Within the scope of TÜBİTAK Teydep 1507, it has successfully completed an R&D project in the dosage form of lyophilized powder vial containing peptide in 2016.

All R&D studies are carried out in the CT Pharma Research R&D laboratory located in the TUBITAK Martek Technology Development Zone.